Publications

Source: OncLive, March 2019 The FDA has approved the PD-1 inhibitor pembrolizumab (Keytruda) for the adjuvant treatment of patients with high-risk stage III melanoma with lymph node involvement following complete…

Source: MDLinx, March 2019 In a small study of melanoma patients, a high-fiber diet was associated with higher gut microbiome diversity and better response to immunotherapy, while probiotic therapy had…

Source: MDLinx, March 2019 In view of the observation that eosinophil cationic protein (ECP) mediates anticancer effects, such as tissue remodelling and cytotoxic activity, researchers examined the prognostic value of…